Literature DB >> 16099396

Anandamide as an intracellular messenger regulating ion channel activity.

Mario van der Stelt1, Vincenzo Di Marzo.   

Abstract

The endocannabinoid anandamide (N-arachidonoylethanolamine) was proposed to be an extracellular retrograde messenger, which regulates excitability of neurons by cannabinoid CB1 receptor-dependent inhibition of neurotransmitter release. Recent findings indicate that the neuromodulatory actions of anandamide might be more complex. Anandamide has been shown to directly modulate various ion channels, such as alpha7-nicotinic acetylcholine receptors, T-type Ca2+ channels, voltage-gated and background K+-channels and Transient Receptor Potential Vanilloid type 1 (TRPV1) channels. The binding site of anandamide at some of these ion channels appears to be intracellular or at the bilayer interface. This rises the intriguing possibility that anandamide, prior to its release into the synaptic cleft, may regulate ion homeostasis and excitability of neurons as an intracellular modulator of ion channels independent of its action at cannabinoid CB1 receptors. This possibility might extend the concept of anandamide as an endocannabinoid retrograde messenger and may have profound implications for its role in neurotransmission and neuronal function. Here, we will review the evidence for this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099396     DOI: 10.1016/j.prostaglandins.2004.09.007

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  31 in total

1.  Differences in peripheral endocannabinoid modulation of scratching behavior in facial vs. spinally-innervated skin.

Authors:  Jessica Marie Spradley; Auva Davoodi; Leland Bruce Gee; Mirela Iodi Carstens; E Carstens
Journal:  Neuropharmacology       Date:  2012-06-06       Impact factor: 5.250

2.  Pitfalls and solutions in assaying anandamide transport in cells.

Authors:  Sergio Oddi; Filomena Fezza; Giuseppina Catanzaro; Chiara De Simone; Mariangela Pucci; Daniele Piomelli; Alessandro Finazzi-Agrò; Mauro Maccarrone
Journal:  J Lipid Res       Date:  2010-05-06       Impact factor: 5.922

3.  Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.

Authors:  Chitra Sridar; Natasha T Snider; Paul F Hollenberg
Journal:  Drug Metab Dispos       Date:  2011-02-02       Impact factor: 3.922

Review 4.  The complications of promiscuity: endocannabinoid action and metabolism.

Authors:  S P H Alexander; D A Kendall
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

Review 5.  Wiring and firing neuronal networks: endocannabinoids take center stage.

Authors:  Tibor Harkany; Ken Mackie; Patrick Doherty
Journal:  Curr Opin Neurobiol       Date:  2008-06       Impact factor: 6.627

Review 6.  Modulation of T-type calcium channels by bioactive lipids.

Authors:  Jean Chemin; Magali Cazade; Philippe Lory
Journal:  Pflugers Arch       Date:  2014-02-16       Impact factor: 3.657

7.  5,6-EET potently inhibits T-type calcium channels: implication in the regulation of the vascular tone.

Authors:  Magali Cazade; Isabelle Bidaud; Pernille B Hansen; Philippe Lory; Jean Chemin
Journal:  Pflugers Arch       Date:  2013-12-11       Impact factor: 3.657

8.  Endocannabinoids blunt the augmentation of synaptic transmission by serotonin 2A receptors in the nucleus tractus solitarii (nTS).

Authors:  James R Austgen; David D Kline
Journal:  Brain Res       Date:  2013-09-13       Impact factor: 3.252

Review 9.  The role of endogenous molecules in modulating pain through transient receptor potential vanilloid 1 (TRPV1).

Authors:  Sara L Morales-Lázaro; Sidney A Simon; Tamara Rosenbaum
Journal:  J Physiol       Date:  2013-04-22       Impact factor: 5.182

10.  Capsaicin-sensitive primary sensory neurons in the mouse express N-Acyl phosphatidylethanolamine phospholipase D.

Authors:  B Nagy; C Fedonidis; A Photiou; J Wahba; C C Paule; D Ma; L Buluwela; I Nagy
Journal:  Neuroscience       Date:  2009-03-25       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.